Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685–95.
Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Exp Clin Cardiol. 2007;12(1):17–28.
CAS PubMed PubMed Central Google Scholar
Mukherjee D. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2009;23(3):335–45.
Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988–1994 to 1999–2004. J Diabetes Complications. 2010;24(6):382–91.
Wong ND, Zhao Y, Patel R, Patao C, Malik S, Bertoni AG, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study. Diabetes Care. 2016;39(5):668–76.
Article CAS PubMed PubMed Central Google Scholar
Fan W, Song Y, Inzucchi SE, Sperling L, Cannon CP, Arnold SV, et al. Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the Diabetes Collaborative Registry. Diabetes Obes Metab. 2019;21(5):1121–7.
Article CAS PubMed Google Scholar
Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258–79.
Article PubMed PubMed Central Google Scholar
Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014;63(6):745-54.e6.
Zhang P-Z, Guo D, Liu C-Q, Chen N, Liu J-F, Lei X-Z, et al. Mobile app–based intervention and cardiovascular risk factors in patients with uncontrolled type 2 diabetes: a randomized clinical trial. JAMA Netw Open. 2025;8(9):e2529762-e.
Article PubMed PubMed Central Google Scholar
Nelson LA, Greevy RA, Spieker A, Wallston KA, Elasy TA, Kripalani S, et al. Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial. Diabetes Care. 2021;44(1):26–34.
Dobson R, Whittaker R, Jiang Y, Maddison R, Shepherd M, McNamara C, et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ. 2018;361:k1959.
Article PubMed PubMed Central Google Scholar
Dobson R, Whittaker R, Jiang Y, McNamara C, Shepherd M, Maddison R, et al. Long-term follow-up of a randomized controlled trial of a text-message diabetes self-management support programme, SMS4BG. Diabet Med. 2020;37(2):311–8.
Article CAS PubMed Google Scholar
Huo X, Krumholz HM, Bai X, Spatz ES, Ding Q, Horak P, et al. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial. Circ Cardiovasc Qual Outcomes. 2019;12(9):e005805.
Farmer A, Bobrow K, Leon N, Williams N, Phiri E, Namadingo H, et al. Digital messaging to support control for type 2 diabetes (StAR2D): a multicentre randomised controlled trial. BMC Public Health. 2021;21(1):1907.
Article CAS PubMed PubMed Central Google Scholar
Fortmann AL, Gallo LC, Garcia MI, Taleb M, Euyoque JA, Clark T, et al. Dulce digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care. 2017;40(10):1349–55.
Article PubMed PubMed Central Google Scholar
Wang Y, Li M, Zhao X, Pan X, Lu M, Lu J, et al. Effects of continuous care for patients with type 2 diabetes using mobile health application: a randomised controlled trial. Int J Health Plann Manage. 2019;34(3):1025–35.
Dong Y, Wang P, Dai Z, Liu K, Jin Y, Li A, et al. Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: A randomized clinical trial. Med (Baltim). 2018;97(50):e13632.
Lee DY, Park J, Choi D, Ahn H-Y, Park S-W, Park C-Y. The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: a randomized, controlled, open-label study. Sci Rep. 2018;8(1):3642.
Article PubMed PubMed Central Google Scholar
Gunawardena KC, Jackson R, Robinett I, Dhaniska L, Jayamanne S, Kalpani S, et al. The influence of the Smart Glucose Manager Mobile Application on diabetes management. J Diabetes Sci Technol. 2019;13(1):75–81.
Kusnanto WKAJ, Suprajitno, Arifin H. DM-calendar app as a diabetes self-management education on adult type 2 diabetes mellitus: a randomized controlled trial. J Diabetes Metab Disord. 2019;18(2):557–63.
Article CAS PubMed PubMed Central Google Scholar
Leung N, Waki K, Nozoe S, Enomoto S, Saito R, Hamagami S, et al. Efficacy of Save Medical Corporation (SMC)-01, a smartphone app designed to support type 2 diabetes self-management based on established guidelines: randomized controlled trial. J Med Internet Res. 2024;26:e53740.
Article PubMed PubMed Central Google Scholar
Ndahiriwe CC, Gasana J, Nshimiyimana J, Bavuma C, Bucyana E, Manirafasha C, et al. Effectiveness of smartphone application “Gororokapp” for type 2 diabetes patients’ self-management in Rwanda: a randomized controlled trial. Rwanda J Med Health Sci. 2024;7(1):79–88.
Article PubMed PubMed Central Google Scholar
Gerber BS, Biggers A, Tilton JJ, Smith Marsh DE, Lane R, Mihailescu D, et al. Mobile health intervention in patients with type 2 diabetes: a randomized clinical trial. JAMA Netw Open. 2023;6(9):e2333629-e.
Article PubMed PubMed Central Google Scholar
Boels AM, Vos RC, Dijkhorst-Oei LT, Rutten G. Effectiveness of diabetes self-management education and support via a smartphone application in insulin-treated patients with type 2 diabetes: results of a randomized controlled trial (TRIGGER study). BMJ Open Diabetes Res Care. 2019;7(1).
Li R, Liang N, Bu F, Hesketh T. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2020;8(3):e17776.
Article PubMed PubMed Central Google Scholar
Siopis G, Moschonis G, Eweka E, Jung J, Kwasnicka D, Asare BY, et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health. 2023;5(3):e144–59.
Article CAS PubMed Google Scholar
Yap HJ, Lim JJJ, Tan SD, Ang CS. Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis. J Hypertens. 2024;42(9):1490–504.
Article CAS PubMed Google Scholar
Zhou Y, Li SJ, Huang RQ, Ma HM, Wang AQ, Tang XY, et al. Behavior change techniques used in self-management interventions based on mHealth apps for adults with hypertension: systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. 2024;26:e54978.
Article PubMed PubMed Central Google Scholar
Kassavou A, Wang M, Mirzaei V, Shpendi S, Hasan R. The association between smartphone app-based self-monitoring of hypertension-related behaviors and reductions in high blood pressure: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2022;10(7):e34767.
Article PubMed PubMed Central Google Scholar
Yoon M, Hur T, Park SJ, Jo SH, Kim EJ, Kim SJ, et al. Self-monitoring of blood pressure and feedback via mobile app in treatment of uncontrolled hypertension: the SMART-BP randomized clinical trial. Mayo Clin Proc. 2025;100(5):840–53.
Article CAS PubMed Google Scholar
Liu F, Song T, Yu P, Deng N, Guan Y, Yang Y, et al. Efficacy of an mHealth app to support patients’ self-management of hypertension: randomized controlled trial. J Med Internet Res. 2023;25:e43809.
Comments (0)